Posts

Showing posts from February, 2019

Upstream cell culture processes for the production of therapeutic proteins

Image
These days, the biopharmaceutical industry is rapidly growing with the introduction  of new technologies and advancements. The therapeutic proteins play an important role in the upstream cell culture procedures. These proteins are engineered in lab for the use in pharma industries and these affect covalent bonds, enzymes. These proteins are really effective in revolutionary treatment of various diseases and vivo. It can allow individual treatment with specific and targeted therapeutic procedure as it compensates the deficiency of protein body. These proteins have less potential with common biological procedures and can cause adverse results. It can be tolerated in good manner and there are lesser chances of immune responses which elicit. There is no need for gene therapy when the replacement treatment can be done with cell line development and it would be done with the help of therapeutic proteins. It is FDA approved and clinical development which is really fast. One c...

Increasing the importance of CMOs to Pharmaceutical companies

Image
These days,   most of the pharmaceutical companies are becoming successful and this is happening due to the consistent patent, research, and development of new drugs which can cure harmful diseases effectively. Even if the drugs can’t cure the people completely but at least it can have a better effect on the whole population. Companies also have to focus on profits and revenue because the margins are getting squeezed due to generics ooding. There are tight rules and regulations made by the government to ensure the best quality of medicine and this is finally enhancing the awareness of people in this field. Now the pharma organizations not only have to pay attention to their profits but they also have to focus on bottom line prices. In recent times, CMOs are getting importance in the pharmaceutical market. The CMOS can provide different types of services relevant to the business at reasonable prices but that only on a contract basis. The activities like formula devel...

Check out the different between Biotech and Biopharma companies

Image
With the advancing technological world, the medical field is also developing at a fast pace. When a person is not from the medical field, then he/she can’t find the actual difference between biotech and biopharmaceutical companies . Both of the companies deal with medicines and drugs but there is a huge difference between both of them.  In biopharmaceutical companies, the best methods are used for the production and design of products but in biotech companies, whole research is done after which development takes place. Various tests are conducted before the manufacturing starts and then the work of selling drugs is done at the final stage. Know about biotechnology This technology is based on the subject biology and all the products which use living organisms are qualified in biotechnology. There are some people who think that it is a modern application which treats diseases and enhance the level of the environment while improves manufacturing processes also. There a...

Check out advancements in the development of therapeutic monoclonal antibodies

Image
Do you know that the Monoclonal antibodies are a very important part of the biopharma market? Not only is it a part of biopharmaceutical companies but also helping in generating huge revenue. These are quite valuable products and the dose of these products is in huge requirement as compared to the biological products present in the market. So, large scale production of Monoclonal antibodies is required and it should be really efficient. There should be some ways to enhance cost-effective manufacture procedures. In the last few years, several improvements are seen in this area like large scale culture production of cells and cell generation to enhance the productivity of monoclonal antibodies. The costs are needed to be reduced and productions need to be increased at a higher level but this creates a challenge in front of the monoclonal antibody manufacturing companies. When the commercialization of the initial monoclonal antibody started, then from that time it became the e...